Article
Mice with genetically altered glutamate receptors as models of schizophrenia: a comprehensive review.
Neuroscience and biobehavioral reviews - 1 Mar 2010
Inta Dragos, Monyer Hannah, Sprengel Rolf, Meyer-Lindenberg Andreas, Gass Peter
Abstract excerpt
Recent clinical evidence for the effectiveness of new antipsychotic drugs that specifically target glutamate receptors has rekindled interest in the glutamatergic system regarding pathophysiology and treatment of schizophrenia. The glutamatergic hypothesis of schizophrenia was triggered by the clinical/behavioural observation that NMDA receptor antagonists can induce psychosis in humans and abnormal behaviour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
